Clinical Trials Directory

Trials / Completed

CompletedNCT03140644

SARCOLOWDOSE : Ultra-low Dose CT Scan and MRI in Thoracic Sarcoidosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
196 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to evaluate the diagnostic agreement between, on the one hand, ultra-low dose CT and MRI with UTE pulse sequences, and on the other hand, standard CT scan, to quantify lung parenchyma patterns in thoracic sarcoidosis.

Detailed description

Sarcoidosis is a chronic disease involving lung and mediastinum in more than 90% of cases. Five to 25% of thoracic sarcoidosis are complicated by a severe fibrotic lung disease. Computed tomography (CT) is critical for the diagnosis of thoracic sarcoidosis as well as for therapeutic management. Repeated CT examinations, sometimes all life long, raise the issue of the cumulative radiation dose and subsequent risk of cancer, thus pushing the need for imaging techniques using low or no radiation dose. Based upon tube voltage and current reduction as well as iterative recontsruction, ultra-low dose CT (ULD CT) allows to lower the dose up to that of a traditional chest X-ray. Magnetic resonance imaging (MRI) using Ultrashort echo time (UTE) enables lung parenchyma imaging with high signal-to-noise and spatial resolution.

Conditions

Interventions

TypeNameDescription
OTHERPatients with thoracic sarcoidosisUltra-low dose CT scan and MRI with UTE

Timeline

Start date
2017-05-16
Primary completion
2021-10-15
Completion
2021-10-15
First posted
2017-05-04
Last updated
2023-05-17

Locations

7 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03140644. Inclusion in this directory is not an endorsement.